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Background: This study describes the pattern of ultrasonographic contrast enhancement of the pancreatic body and
left lobe using a second-generation commercial contrast medium (Sonovue) in 10 clinically healthy cats.
Results: Following contrast medium administration, microbubbles were observed within the splenic artery. This was
followed by an inflow of contrast medium into the pancreatic capillary beds, providing a uniformly contrast-enhanced
pancreas at peak intensity (PI). At the time of PI, a replenishment of the splenic and portal veins started and increased
progressively during the wash-out phase. During the wash-out phase, the echogenicity of the pancreatic parenchyma
decreased progressively. Perfusion parameters included arrival time (4.69 ± 1.26 s), time to peak from injection (7.52 ±
1.88 s), time to peak from initial rise (2.84 ± 0.88 s), peak intensity (6.58 ± 2.66 a.u.), and wash-in rate (2.11 ± 1.79 a.u./s).
Conclusions: This perfusion pattern of normal pancreatic parenchyma may be useful for characterising cats with exocrine
pancreatic disorders.
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Abdominal ultrasonography can be a useful diagnostic
tool for the work-up of cats with suspected pancreatitis.
The ultrasonographic appearance of the normal feline
pancreas and its age-related changes have been described
[1-3]. Reference ranges for the thickness of the pancreatic
body, lobes and duct have also been reported [4]. A variety
of ultrasonographic changes (i.e., diffuse hypoechogenicity,
pancreatic enlargement, hyperechoic peripancreatic mes-
entery and peritoneal effusion) have been described in cats
with pancreatitis [3,5,6], although the sonographic features
can overlap with other exocrine pancreatic abnormalities
[7-9]. The reported sensitivity of abdominal ultrasonog-
raphy for the diagnosis of feline pancreatitis ranges from
20% to 67% [5,10,11]. This low sensitivity suggests that im-
aging of the inflamed pancreas is more difficult in cats
than in dogs, or that the ultrasonographic appearance of
pancreatitis in cats differs from that reported in dogs [8].* Correspondence: alessia.diana@unibo.it
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unless otherwise stated.In human medicine, contrast enhanced ultrasonog-
raphy (CEUS) is widely applied for identification of pan-
creatic tumours based on their pattern of vascularisation
[12-16]. Furthermore, CEUS accurately detects pancre-
atic necrosis, helping to predict the clinical outcome of
patients with acute pancreatitis [17,18].
There are only a few reports concerning the use of
CEUS for the evaluation of the pancreas in cats [19,20]
and dogs [21-23]. In cats, one study described the quan-
titative CEUS analysis of perfusion in different abdom-
inal organs of healthy cats, including the right
pancreatic lobe [20]. Another study described contrast-
enhanced and colour Doppler ultrasonography of the
pancreas in healthy and diseased cats using a first gener-
ation contrast agent [19]. The pancreatic perfusion in
healthy dogs using either a single bolus injection [21] or
continuous infusion [22], and in dogs with cerulein-
induced acute pancreatitis [23] and with pancreatic tu-
mours [24] were also reported.
The first aim of the present study was to describe
CEUS patterns of the body and the left lobe of the pan-
creas in clinically healthy cats. The second aim was to
evaluate the thickness of the pancreatic left lobe both
before and after injecting the contrast medium.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Study population
Ten clinically healthy client-owned adult cats were used
in this study. Cats represented four breeds including
European short hair (4), Maine Coon (3), Norwegian (2)
and Persian (1). There were three intact males, two neu-
tered males, four intact females and one neutered
female. The age of the cats ranged from 2 to 9 years
(mean ± SD, 5.5 ± 2 years), and the cats’ bodyweight
ranged from 4 to 8.4 kg (mean ± SD, 5.3 ± 1.5 kg).
Cats were considered clinically healthy and had no his-
tory of hepatobiliary, pancreatic or gastrointestinal disease
for the previous 12 months. Physical examination,
complete blood count, serum biochemical analysis includ-
ing feline trypsin-like immunoreactivity (fTLI) and feline
pancreatic lipase immunoreactivity (fPLI) concentrations,
urinalysis and faecal examination for intestinal parasites
were normal. All cats were also negative for feline leukae-
mia virus antigen and feline immunodeficiency virus anti-
body. Informed owner consent was obtained and all
procedures were approved by the Ethical Committee of
the University of Bologna (Authorisation reference num-
ber: 17/72/2012; date of approval 10-01-2012).
Ultrasound imaging
Food was withheld overnight (at least 12 h) prior to im-
aging. All procedures were conducted by the same ultra-
sonographer (AD), using a real-time ultrasound machinea
equipped with a broadband curved array transducer (5–
8 MHz) and a linear array transducer (3–9 MHz). Hair
over the abdomen was clipped, the skin surface was
cleaned with 70% isopropyl alcohol, and coupling gel was
applied. The cats were awake and were restrained manu-
ally during the examination. With each cat in dorsal or
right lateral recumbency, the body and the left lobe of the
pancreas as well as the portal vein were identified for
CEUS using a subcostal approach. An image of the longi-
tudinal section of the pancreatic body and left lobe was
obtained and the transducer was not moved subsequently
(Figure 1). Contrast-specific software (Pulse Inversion
Harmonic and Power Modulation combined – PMPI)
with a low mechanical index set (0.07) was activated. The
gain setting was regulated to obtain anechoic pancreatic
parenchyma at baseline, and a focal zone was placed just
below the pancreas to minimise microbubbles destruction.
These CEUS settings were tested and standardised in our
ultrasound laboratory and optimised for the ultrasound
machine, probe and application used in this protocol.
The contrast mediumb was prepared and injected by
the same operator, using the following standard proced-
ure. The microbubble dispersion was prepared before
use by injecting through the septum 5 mL of sodium
chloride 9 mg/mL (0.9%) solution for injection to the
contents of the vial. The vial was then shaken vigorouslyfor a few seconds until the lyophilisate was completely
dissolved. Four mL volume of the dispersion was drawn
into a syringe. Just before drawing into the syringe, the
vial was agitated to re-suspend the microbubbles. The
contrast medium was administered manually through an
indwelling cephalic venous 22G catheter as a rapid bolus
of 0.5 mL, followed immediately by a rapid bolus of
4 mL saline.
The images were recorded as cine-segments in DICOM
format of 60 s starting from contrast medium injection,
and were transferred to a personal computer.
Show Case softwarec was used to view the images and to
export selected frames for qualitative analysis. The distri-
bution of the contrast medium enhancement within the
pancreatic lobe was evaluated subjectively as satisfactory or
unsatisfactory, based on the degree of parenchymal en-
hancement and homogeneity at peak intensity (PI). The
CEUS pattern of the pancreatic body and left pancreatic
lobe were evaluated during contrast uptake (wash-in
phase), at PI and during progressive wash-out of contrast
medium. Contrast medium inflow at the splenic vessels
(both artery and vein) and at the portal vein was also
evaluated.
A commercial software programd was used for quantita-
tive computerised analysis of the contrast medium blood
pool phase. A region of interest (ROI) covering the body
and left pancreatic lobe as much as possible was manually
drawn to avoid adjacent major vessels (Figure 2). The ROI
was maintained in the same position by the motion com-
pensation tool of the software. This tool prevents the dis-
placement of the ROI during respiratory motion.
Furthermore, the ROI was adjusted manually on those
frames severely affected by respiratory motion. Artifactual
data from adjacent tissue that moved into the ROI during
respiratory motion were removed manually from the final
data set to reduce noise. The raw data obtained from each
cat were plotted in quantitative time-intensity curves after
fitting of a mathematical algorithm. Only fit-curves with
quality of fitting expressed as r2 equal or more than 0.9
were used for subsequent analysis. The following perfu-
sion variables were recorded: arrival time (AT, expressed
in s), defined as the time when the contrast signal in-
creases to greater than double the baseline value in the
time-intensity curve; time to peak from injection (TTPinj,
expressed in s); time to peak from initial rise (TTPinr,
expressed in s); peak intensity (PI, expressed in arbitrary
units [a.u.]); and wash-in rate (Wi, expressed in a.u./s), de-
fined as the slope of the curve during the wash-in phase
(Figure 2). Wash-in was calculated as the maximal change
rate, using data points 10% above baseline and 10% below
peak to exclude variability at the toe and shoulder of the
time-intensity curve, respectively. Using an electronic cal-
liper, the thickness of the left pancreatic lobe was mea-
sured by dual imaging mode from the grey scale image
Figure 2 Contrast enhancement image and the grey scale image (A) and signal intensity in arbitrary units (a.u.) as a function of time
in seconds (s) (B) of the pancreatic body and left lobe in a healthy cat. Region of interest is delimited by the green line. The red dotted line
represents the raw data derived from the quantification. The continuous red line corresponds to the curve given automatically by the software using a
proprietary algorithm. The image is cut on purpose between 1 and 5 s for formatting reasons. AT, arrival time; TTPinr, time to peak from initial rise;
TTPinj, time to peak from injection; PI, peak intensity; Wi, wash-in rate.
Figure 1 Longitudinal section of the pancreatic body and left lobe of a healthy cat in the contrast enhancement image (A) and the
grey scale image (B), respectively. An example of left lobe thickness measurements is showed. The white dotted line represents the thickness
of the left pancreatic lobe at peak enhancement.
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image at peak intensity, respectively (Figure 1). The mean
value of three measurements for each cat was used for
analysis.
Statistical analysis
The data were then regressed for significance of linearity
using a D’Agostino-Pearson test and expressed as means
and standard deviations (SD). A two-tailed Student’s t test
was used to compare the thickness of the left pancreatic
lobe before and after contrast medium injection. A
P < 0.05 value was considered statistically significant.
Statistical analyses were performed using a commercial
software packagee.
Results
The pancreatic body and left lobe were identified in all
cats. The margins of the pancreas were clearly recognised
in six cats, while in the remaining four cats they appeared
ill-defined. No adverse effects were noticed in any of the
cats during or after the injection of the contrast medium.
Contrast enhancement was judged subjectively to be satis-
factory in nine of the ten cats. In one cat, the contrast up-
take of the pancreas was considered insufficient and this
cat was excluded from quantitative analyses. Following
contrast medium administration, microbubbles were first
seen in the splenic artery dorsally or caudo-dorsally to the
left pancreatic lobe. This was followed by inflow of theFigure 3 A representative contrast-enhanced ultrasound sequence (A
plane after the injection of Sonovue. Each image illustrates contrast enha
contrast medium is visible in the splenic artery (SA). (B) Microbubbles are still
also receive some contrast material. The splenic vein appears anechoic on the
pancreatic lobe at peak enhancement. Some microbubbles are starting to fill
progressively becomes hypoechoic, while the pancreatic vein (SV) reaches its
vein (PV).contrast medium into the capillary bed of the pancreatic
parenchyma, providing a well-marginated and uniformly
contrast-enhanced pancreas at PI. An anechoic non-
contrast-enhanced tubular or round structure (i.e., the
splenic vein) was visualised immediately adjacent to the
splenic artery in seven cats. During the wash-out period,
the echogenicity of the pancreatic parenchyma reduced
progressively, while the pancreatic artery showed residual
intravascular contrast, which was subjectively judged to be
less intense compared to the previous phases. The micro-
bubble replenishment of the splenic and portal vein
started at the PI of the pancreatic parenchyma and in-
creased progressively during the wash-out phase, reaching
a saturation of the signal. During PI, the pancreatic mar-
gins were always sharp and well-defined. This perfusion
pattern of the left pancreatic lobe was consistently ob-
served in all ten cats (Figure 3). In particular, replenish-
ments of the splenic artery, splenic vein and portal vein
were observed in ten, seven and ten cats, respectively.
Quantitative computerised analysis of enhancement of the
pancreatic body and left lobe was performed in nine cats
and is summarised in Table 1.
Measurements of the left pancreatic lobe, obtained from
the grey scale image before contrast medium injection and
from the contrast image at PI, are summarised in Table 2.
There was a statistically significant difference between the
thickness of the left pancreatic lobe before and after con-
trast medium injection (P < 0.0001)., B, C and D) of a normal left pancreatic lobe in a longitudinal
ncement on the left and the grey scale image on the right. (A) The
visible in the splenic artery while the pancreatic parenchyma is starting to
contrast-enhanced image. (C) Homogeneous enhancement of the entire
the splenic vein (SV). (D) During the wash-out phase, the parenchyma
peak in contrast uptake. The contrast medium is also visible in the portal
Table 1 Results of quantitative contrast-enhanced ultra-
sonography of the pancreatic body and left lobe in nine
healthy cats
Parameter Mean SD
AT (s) 4.69 1.26
TTPinj (s) 7.52 1.88
PI (a.u.) 6.58 2.66
TTPinr (s) 2.84 0.88
Wi (a.u./s) 2.18 1.79
AT, arrival time; TTPinj, time to peak from injection; PI, peak intensity; TTPinr,
time to peak from initial rise; Wi, wash-in rate.
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Arterial blood flow is supplied to the pancreas by the
splenic artery, the hepatic artery and the caudal pancreati-
coduodenal artery. In particular, the left lobe, which is lo-
cated parallel to the greater curvature of the stomach, is
supplied by the splenic artery. This artery is the left branch
of the coeliac artery; it runs in the greater omentum along
the dorsocaudal surface of the left lobe of the pancreas
[25] and gives off between two to six pancreatic branches
for the left pancreatic lobe [26]. In addition to this main
vasculature, the left pancreatic lobe is also supplied by a
few small branches of the gastroduodenal artery (which is
one of the two terminal endings of the hepatic artery) and,
rarely, by a long branch of the caudal pancreaticoduodenal
artery [26]. The body of the pancreas is supplied by one to
three very small branches from the origin of the right gas-
tric artery (which is the right branch of the coeliac artery)
and from the gastroduodenal artery [27] or one of its ter-
minal branches, the right gastroepiploic artery [26]. Tribu-
taries of the major arteries of the pancreas penetrate the
pancreatic parenchyma and arborise into one of threeTable 2 Left pancreatic lobe thickness measured during
grey scale analysis and contrast-enhanced ultrasound in
ten healthy cats
Cat Left pancreatic lobe thickness
Grey scale (mm) Contrast enhancement (mm)
1 5.3 5.8
2 5.2 6.5
3 7.7 8.7
4 5.8 6.5
5 5.4 5.4
6 6.6 7
7 4.2 4.7
8 4.6 5.5
9 5.7 6.6
10 4 5.5
Mean 5.5 6.2
SD 1.1 1.1types of terminal afferent arterioles: capillary arterioles
that surround and supply the exocrine pancreatic acini (i.
e., acinar arterioles), capillary arterioles that supply the
ductal system, and afferent arterioles that supply the capil-
lary glomerulus of the islets of Langerhans (i.e., insular ar-
terioles) [25-27]. A detailed description of the pancreatic
vascular distribution is shown in Figure 4.
All cats showed a contrast-enhanced ultrasonographic
pattern that followed the normal anatomic distribution of
the vasculature described above. After the administration
of the microbubble contrast agent, the splenic artery filled
up rapidly. The intense and homogenous enhancement of
the pancreatic parenchyma depends on small pancreatic
branches of the splenic artery that arborise into a dense
capillary network inside the pancreatic lobe. The wash-out
phase was characterised by a gradual decrease of contrast
medium within the pancreatic parenchyma, and an in-
crease of contrast medium within the splenic and portal
veins. This perfusion pattern is quite similar to that re-
ported in previous CEUS studies performed in dogs
[21,22], although those studies only evaluated the right
pancreatic lobe and the adjacent duodenum. As described
above, the blood supply to the right pancreatic lobe is dif-
ferent from that to the left lobe and depends on theFigure 4 Diagram of the distribution of the branches of the
coeliac a. and cranial mesenteric a. to the pancreas. 1, aorta; 2,
coeliac a.; 3, cranial mesenteric a.; 4, hepatic a.; 5, left gastric a.; 6,
splenic a.; 7, right gastric a.; 8, gastroduodenal a.; 9, cranial
pancreaticoduodenal a.; 10, left gastroepiploic a.; 11, caudal
pancreaticoduodenal a.; 12, jejunal aa.
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tomose within the gland [26,27]. In a previous study con-
ducted in healthy cats, a specific pattern of pancreatic
perfusion was not described, as the author reported that
the quantitative contrast enhanced the ultrasonographic
analysis of perfusion in abdominal organs, including the
pancreas [20]. In our study, good quality time-intensity
curves were obtained for nine cats. In one cat, incorrect
positioning of the intravenous catheter caused inadequate
concentration of the contrast medium. Comparing our re-
sults of quantitative perfusion variables to those previously
reported for healthy anaesthetised cats [20], the AT was
similar to this previous study, while TTPinj and TTPinr
were slightly higher in our cats. These results were ex-
pected, since several factors can influence quantitative
CEUS parameters. For example, the study by Leinonen
et al. employed general anaesthesia, and it has been previ-
ously demonstrated that different anaesthetic agents can
induce cardiovascular changes which may influence con-
trast medium dynamics and markedly affect microbubble
distribution and delivery [28]. Sedation and anaesthesia
were avoided purposely in our cats, in order to obtain
baseline values without iatrogenic changes in blood pres-
sure and heart rate. Secondly, our analyses were per-
formed at the level of the left pancreatic lobe, whereas
Leinonen et al. did not specify the location for ROI mea-
surements in the pancreatic parenchyma [20]. As previ-
ously mentioned, the pancreatic blood supply is quite
different between the left and the right lobes. Several other
factors, such as technical variables (e.g., gain setting,
mechanical index and/or scanning depth), contrast agent
type and dose, injection technique (bolus vs. constant rate
infusion) and patient-related factors (e.g., heart rate, blood
pressure and/or respiratory rate) can influence quantita-
tive variables [28,29].
In the present study, we tried to reduce the technical
variables as much as possible, keeping the same contrast
ultrasound settings for all cats. A single 0.5 mL bolus
dose of microbubble contrast medium was used for each
cat. This dose was chosen on the basis of a previous
study conducted by our group for the ultrasonographic
evaluation of the small bowel using microbubble con-
trast medium in healthy cats [30].
The right lateral or dorsal recumbency was successfully
used to evaluate the left pancreatic lobe, ventrally and medi-
ally to the spleen and the portal vein in the same image.
The edges of the left pancreatic lobe appeared ill-
defined in four cats during B-mode ultrasonography, while
they were clearly delineated from surrounding organs in
contrast images for all cats. Furthermore, a statistical dif-
ference of the thickness of the left pancreatic lobe when
measured from the grey scale image or the contrast-
enhanced image was found. This finding can be explained
on the basis of the abovementioned increased accuracy indefining pancreatic margins once the contrast medium
has been injected. Pancreatic dimensions may not be cor-
rectly measured in grey scale images since peripancreatic
fat has a similar echogenicity to the pancreatic paren-
chyma. This is unlikely to occur in contrast-enhanced im-
ages since the peritoneal fat doesn’t show contrast uptake,
while the pancreatic parenchyma is highlighted by the
microbubbles upon a dark background. This should be
considered when accuracy is needed to measure pancre-
atic dimensions and outline its boundaries.
Like the other ultrasonographic techniques (i.e.,
B-mode sonography and Doppler sonography), CEUS is
susceptible to some artefacts creating misinterpretation
[31-33]. In particular, the slice thickness and the pseu-
doenhancement artefacts can produce an overestimation
of the true perfused areas [31-33]. However, these arte-
facts occur in specific conditions such as deep region of
investigation and low emission frequency probes [32,33].
The anatomical position of the feline pancreas, associ-
ated with the high frequency probe used in this study,
makes an overestimation of the pancreatic measure-
ments unlikely.
This study has some limitations that need to be empha-
sised. First, the population of cats prospectively recruited
was considered healthy only on the basis of clinical and la-
boratory findings. No surgical biopsies were taken and,
therefore, histological confirmation of the normality of the
pancreas was not available. Second, the CEUS was per-
formed using a single bolus of contrast medium and di-
rected only at the left pancreatic lobe. A recent report
demonstrated that continuous infusion of contrast medium
provided better detail of the vascular distribution as well as
a prolonged enhancement of the pancreas, which was de-
termined to be useful in detecting differences in pancreatic
perfusion during diffuse disease [23].
Conclusions
In conclusion, we demonstrated that CEUS can be used
for evaluation of the pancreatic parenchyma in healthy
cats. In particular, the injection of a microbubble con-
trast medium allows a precise definition of pancreatic
edges. A distinctive contrast perfusion pattern is de-
scribed. The baseline data described here may be useful
as a reference for future assessment of cats with pancre-
atic disease.
Endnotes
aiU22 ultrasound system, Philips Healthcare, Monza, Italy.
bSonovue, Bracco® diagnostic, Milano, Italy.
cShowcase software, Trillium Technology, Ann Arbor,
MI.
dQLAB quantification software, Philips Healthcare,
Monza, Italy.
ePrism 5®, GraphPad Software Inc., San Diego, CA.
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